Skip to Main Content

Paper Details

Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors.
Nat Med
277
2020
IL-8, Serum interleukin-8, advanced cancers, docetaxel, everolimus, intratumor neutrophils, ipilimumab, nivolumab, patients, serum IL-8, serum interleukin-8, tumor
Author NameAffiliation
Alice M Walsh
Jianlei GuSchool of Public Health, Yale University
Hongyu ZhaoSchool of Public Health, Yale University
  • 1 - 3

Datasets

Release 1.2